Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 6034-6039

  Liu, Lide ^a   Tewari, Ram P ^b   Williamson, Peter R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; FERRIC ION; FERROUS ION; HYDROXYL RADICAL; IRON; LACCASE; LEVODOPA; MANNITOL; MELANIN; OXIDOREDUCTASE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IRON METABOLISM; LUNG ALVEOLUS MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

EID: 0032755657     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.6034-6039.1999     Document Type: Article

References (45)

1. Alford, C. E., T. E. King, Jr., and P. A. Campbell. 1991. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J. Exp. Med. 174:459-466.
2. Alspaugh, J. A., and D. L. Granger. 1991. Inhibition of Cryptococau neoformam replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291-2296.
3. Blasi, E., R. Barluzzi, R. Mazzola, B. Tancini, S. Saleppico, M. Puliti, L. Pitzurra, and F. Bistoni. 1995. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglia cell line. J. Neuroimmunol. 58:111-116.
4. Britigan, B. E., and B. L. Edeker. 1991. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J. Clin. Investig. 88:1092-1102.
5. Britigan, B. E., G. M. Rosen, Y. Chai, and M. S. Cohen. 1986. Do human neutrophils make hydroxyl radical? J. Biol. Chem. 261:4426-4431.
6. Britigan, B. E., H. R. Ratcliffe, G. R. Buettner, and G. M. Rosen. 1996. Binding of myeloperoxidase to bacteria: effect on hydroxyl radical formation and susceptibility to oxidant-mediated killing. Biochim. Biophys. Acta 1290:231-240.
7. Chang, Y. C., and K. J. Kwon-Chung. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
8. Chaturvedi, V., B. Wong, and S. L. Newman. 1996. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J. Immunol. 156:3836-3840.
9. Diamond, R. D., R. K. Root, and J. E. Bennett. 1972. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J. Infect. Dis. 125:367-376.
10. Facchetti, F., W. Vermi, S. Florentini, M. Chilosi, A. Caruso, M. Duse, L. D. Notarangelo, and R. Badolato. 1999. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. Am. J. Pathol. 154:145-152.
11. Farias-Eisner, R., G. Chaudhuri, E. Aeberhard, and J. M. Fukuto. 1996. The chemistry and tumoricidal activity of nitric oxide/hydrogen peroxide and the implications to cell resistance/susceptibility. J. Biol. Chem. 271:6144-6151.
12. Fiskin, A. M., M. C. Zalles, and R. G. Garrison. 1990. Electron cytochemical studies of Cryptococcus neoformans grown on uric acid and related sources of nitrogen. J. Med. Vet. Mycol. 28:197-207.
13. Gadebusch, H. H. 1966. On the mechanism of cytotoxicity by cationic tissue proteins for Cryptococcus neoformans. Z. Naturforsch. Sect. B 21:1048-1051.
14. Ganz, T., M. E. Selsted, D. Szklarek, S. S. L. Harwig, K. Daher, D. F. Bainton, and R. I. Lehrer. 1985. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Investig. 76:1427-1435.
15. Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1988. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Investig. 81:1129-1136.
16. Hibbs, J. B., Jr., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deaminase and amino nitrogen oxidation to nitrite. Science 197:473-476.
17. Hiemstra, P. S., P. B. Eisenhauer, L. S. Harwing, M. T. van den Barselaar, R. van Furth, and R. I. Lehrer. 1993. Antimicrobial proteins of murine macrophages. Infect. Immun. 61:3038-3046.
18. Hoepelman, I. M., W. A. Bezemer, C. M. J. E. Vandenbroucke-Grauls, J. J. M. Marx, and J. Verhoef. 1990. Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes. Infect. Immun. 58:26-31.
19. Jacobs, D. H., and S. B. Tinnell. 1993. Antioxidant function of fungal melanin. J. Bacteriol. 175:7102-7104.
20. Jacobson, E. S., and S. E. Vartivarian. 1992. Iron assimilation in Cryptococcus neoformans. J. Med. Vet. Mycol. 30:443-450.
21. Jelinek, J., and A. Jensen. 1991. Catecolamine concentrations in plasma and organs of the fetal guinea pig during normoxemia, hypoxemia, and asphyxia. J. Dev. Physiol. 15:145-152.
22. Jiang, X., and C. L. Baldwin. 1993. Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon-γ. Cell. Immunol. 148:397-407.
23. Kwon-Chung, K. J., I. Polacheck, and T. Popkin. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J. Bacteriol. 150:1414-1421.
24. Lee, S. C., D. W. Dickson, C. F. Brosnan, and A. Casadevall. 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180:365-369.
25. Levitz, S. M., and D. J. Dibenedetto. 1989. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J. Immunol. 142:659-665.
26. Liochev, S. 1996. The role of iron-sulfur clusters in in vivo hydroxyl radical production. Free Radic. Res. 25:369-384.
27. Liu, L., K. Wakamatsu, S. Ito, and P. R. Williamson. 1999. Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice. Infect. Immun. 67:108-112.
28. Lovchik, J. A., C. R. Lyons, and M. F. Lipstomb. 1995. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13:116-124.
29. Messerschmidt, A., and R. Huber. 1990. The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin. Modelling and structural relationships. Eur. J. Biochem. 187:341-352.
30. Murray, H. W., and D. M. Cartelli. 1983. Killing of intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-depen3 dent and -independent Leishmaniacidal activity. J. Clin. Investig. 72:32-44.
31. Nosanchuk, J. D., P. Valadon, M. Feldmesser, and A. Casadevall. 1999. Melanization of Cryptococcus neoformans in murine infection. Mol. Cell. Biol. 19:745-750.
32. Nyhus, K. J., A. T. Wilborn, and E. S. Jacobson. 1997. Ferric iron reduction by Cryptococcus neoformans. Infect. Immun. 65:434-438.
33. Pinner, R. W., R. A. Hajjeh, and W. G. Powderly. 1995. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl. 1):S103-S107.
34. Polacheck, I. 1991. The discovery of melanin production in C. neoformans and its impact on diagnosis and the study of virulence. Zentbl. Bakteriol. 276:120-123.
35. Rosen, G. M., S. Pou, C. L. Ramos, M. S. Cohen, and B. E. Britigan. 1995. Free radicals and phagocytic cells. FASEB J. 9:200-209.
36. Salas, S. D., J. E. Bennett, K. J. Kwon-Chung, J. R. Perfect, and P. R. Williamson. 1996. Effect of the laccase gene, CNLACl, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:377-386.
37. Silva, D., S. Davis-Kaplan, J. Fergestad, and J. Kaplan. 1997. Purification and characterization of Fet3 protein, a yeast homologue of ceruloplasmin. J. Biol. Chem. 272:14208-14213.
38. Staib, F. 1962. Cryptococcus neoformans and Guizotia abyssinica (syn. G. oleifera D. C.) (farbreadktion fur C. neoformans). Z. Hyg. 148:466-475.
39. Tohyama, M., K. Kawakami, M. Futenma, and A. Saito. 1996. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide. Clin. Exp. Immunol. 103:436-441.
40. Walker, L., and D. B. Lowries. 1981. Killing of Mycobacterium microti by immunologically activated macrophages. Nature 293:69-71.
41. Wang, Y., and A. Casadevall. 1994. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 62:3004-3007.
42. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
43. Williamson, P. R. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:656-664.
44. Williamson, P. R., K. Wakamatsu, and S. Ito. 1998. Melanin biosynthesis in Cryptococcus neoformans. J. Bacteriol. 180:1570-1572.
45. Zhang, S., A. Vanna, and P. R. Williamson. 1999. The yeast Cryptococcus neoformans uses "mammalian" enhancer sites in the regulation of the virulence gene, CNLACl. Gene 227:231-240.